Caribou Biosciences (CRBU) Equity Income (2022 - 2024)
Caribou Biosciences (CRBU) reported Equity Income of -$14000.0 for Q3 2024, down 250.0% year-over-year from $9333.3 in Q4 2023, and up 86.27% quarter-over-quarter from -$102000.0 in Q2 2024.
Caribou Biosciences (CRBU) Equity Income (2022 - 2024) Analysis & Trends
Caribou Biosciences (CRBU) has 3 years of Equity Income data on file, last reported at -$14000.0 in Q3 2024.
- Equity Income for Q3 2024 came in at -$14000.0, down 250.0% year-over-year; the trailing twelve-month figure through Sep 2024 was -$125000.0 (down 119.3% YoY), and the FY2023 annual result was -$6000.0, up 95.49% from the prior year.
- Equity Income rose to -$14000.0 in Q3 2024 per CRBU's latest filing, from -$102000.0 in the prior quarter.
- Over five years, Equity Income peaked at $31000.0 in Q3 2022 and troughed at -$102000.0 in Q2 2024.
- A 3-year average of -$25500.0 and a median of -$14500.0 in 2023 frame the typical range for Equity Income.
- The sharpest annual moves came in 2023 and 2024: Equity Income soared 237.5% in 2023, then sank 563.64% in 2024.
- A 3-year view of Equity Income shows it stood at -$60000.0 in 2022, then surged by 85.0% to -$9000.0 in 2023, then sank by 55.56% to -$14000.0 in 2024.
- Business Quant data shows CRBU's Equity Income at -$14000.0 in Q3 2024, -$102000.0 in Q2 2024, and -$9000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -102,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -60,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -88,000.00 |